Morillas-Becerril, L.; Peta, E.; Gabrielli, L.; Russo, V.; Lubian, E.; Nodari, L.; Ferlin, M.G.; Scrimin, P.; Palù, G.; Barzon, L.;
et al. Multifunctional, CD44v6-Targeted ORMOSIL Nanoparticles Enhance Drugs Toxicity in Cancer Cells. Nanomaterials 2020, 10, 298.
https://doi.org/10.3390/nano10020298
AMA Style
Morillas-Becerril L, Peta E, Gabrielli L, Russo V, Lubian E, Nodari L, Ferlin MG, Scrimin P, Palù G, Barzon L,
et al. Multifunctional, CD44v6-Targeted ORMOSIL Nanoparticles Enhance Drugs Toxicity in Cancer Cells. Nanomaterials. 2020; 10(2):298.
https://doi.org/10.3390/nano10020298
Chicago/Turabian Style
Morillas-Becerril, LucÃa, Elektra Peta, Luca Gabrielli, Venera Russo, Elisa Lubian, Luca Nodari, Maria Grazia Ferlin, Paolo Scrimin, Giorgio Palù, Luisa Barzon,
and et al. 2020. "Multifunctional, CD44v6-Targeted ORMOSIL Nanoparticles Enhance Drugs Toxicity in Cancer Cells" Nanomaterials 10, no. 2: 298.
https://doi.org/10.3390/nano10020298
APA Style
Morillas-Becerril, L., Peta, E., Gabrielli, L., Russo, V., Lubian, E., Nodari, L., Ferlin, M. G., Scrimin, P., Palù, G., Barzon, L., Castagliuolo, I., Mancin, F., & Trevisan, M.
(2020). Multifunctional, CD44v6-Targeted ORMOSIL Nanoparticles Enhance Drugs Toxicity in Cancer Cells. Nanomaterials, 10(2), 298.
https://doi.org/10.3390/nano10020298